Gilead Sciences

Vertex Pharmaceuticals

Amgen

Regeneron Pharmaceuticals

IQVIA Hlds

Alnylam Pharmaceuticals

Mettler-Toledo

Biogen

Illumina

Waters

iShares Nasdaq Biotechnology ETF

IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

Moderna

VanEck Vectors Biotech ETF

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

First Trust NYSE Arca Biotechnology Index Fund

Amplify Treatments Testing & Advancements ETF

iShares Genomics Immunology and Healthcare ETF

SPDR S&P Biotech ETF

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

Moderna Inches Closer to Coronavirus Vaccine: ETFs to Shine

Stock futures rocketed higher and are continuing the uptrend in overnight trading on Tuesday after Moderna said its coronavirus vaccine generated antibodies in all patients in an early trial, creating optimism for a swifter economic recovery. Futures on the Dow Jones Industrial Average popped 300 points, while the S&P 500 futures and the Nasdaq 100 [.

Moderna Study Sends Biotech ETFs And Stock Futures Surging

Biotech stocks are breaking out of a seven-year consolidation phase -- and fast. But this rally isn’t slowing down anytime soon.

Biotech Stocks: This Sector Outperformed the Market in Q2

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

Biotech ETF (IBB) Hits a New 52-Week High

Invesco DWA Healthcare Momentum ETF

Biotechnology sector-related exchange traded funds were among the best performers Tuesday as the government program “Operation Warp Speed” allocates billions of dollars for a quick development and delivery of a coronavirus vaccine. On Tuesday, the Invesco DWA Healthcare Momentum Portfolio (NASDAQ: PTH) rose 3.6%, SPDR S&P Biotech ETF (XBI) gained 2.5% and iShares Nasdaq Biotechnology [.

Biotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 Research

Fidelity MSCI Information Technology Index ETF

iShares U.S. Home Construction ETF

iShares U.S. Technology ETF

Invesco Dynamic Building & Construction ETF

Vanguard Information Technology ETF

SPDR S&P Homebuilders ETF

Technology Select Sector SPDR Fund

Here we highlight three sectors that are sizzling with investing opportunities as the second wave of the outbreak is gathering steam.

3 Hot Sector ETFs to Tide Over the Coronavirus Crisis in Q3

BioNTech SE

Pfizer

Sanofi

COVID-19 has been the biggest driver of the stock market this year, whether it was the crash in March or recovery that has taken place since then.

5 Speculative COVID-19 Stocks That Could Still Surge

Zoom Video

Zomedica

The market might be facing turbulence, but Louis Navellier says there are three sectors that should treat investors well regardless   Do you know where the term “dog days of summer” comes from? I assumed it was some broad reference to the heat and humidity of high-summer that causes dogs to lie around doing nothing.

Stocks to Buy for the “Dog Days” of Summer

ARK Genomic Revolution Multi-Sector ETF

As the coronavirus outbreak continues to aggravate, investors are eyeing developments in vaccine or treatments to combat the pandemic.

Biotech ETFs to Gain as Coronavirus Vaccine Hopes Strengthen

AstraZeneca

Gritstone Oncology Inc

Novavax

For the most part, biotech and pharmaceutical companies are involved in the lengthy process of getting their drug candidates to market through clinical trials.

5 FDA COVID-19 Decisions in July Could Make or Break Stocks

Virtus LifeSci Biotech Clinical Trials ETF

With a slew of news to start off the month and quarter, biotech equities and ETFs are moving higher on Wednesday with optimism over developments on the coronavirus vaccine front. The Dow Jones Industrial Average has rallied slightly amid the news, up 0.21%, while the S&P 500 gained 0.63% and the Nasdaq Composite climbed 85%.

Biotech ETFs Gain Amid Vaccine Optimism

Global X Cloud Computing ETF

ProShares Short Dow30

ProShares UltraShort Dow30

First Trust Dow Jones Internet Index Fund

SPDR Gold Trust

iShares Gold Trust

Invesco NASDAQ Internet ETF

First Trust Cloud Computing ETF

As the COVID-19 outbreak continues to aggravate in the United States, we discuss some ETF areas that investors can consider for investing in July.

ETF Areas for July as Second Wave of Coronavirus Hits Hard

Invesco QQQ

An imminent second COVID wave remains a serious threat, but it may be fully priced in by now.

Second COVID Wave? Analysis And Updated Investment Strategy

Global X Robotics & Artificial Intelligence ETF

ProShares Long Online/Short Stores ETF

Amplify Online Retail ETF

Amplify Mobile Payments ETF

ROBO Global Robotics and Automation ETF

Tortoise Digital Payments Infrastructure Fund

Here we highlight a few ETF areas that have the potential to do well in the second half of this year amid the coronavirus crisis.

Try These ETF Areas in Virus-Impacted Second Half of 2020

Invesco Dynamic Biotechnology & Genome ETF

In a sea of red stocks on Wednesday, as fear grips markets due to another spike in coronavirus cases throughout the country, Gilead Sciences is one of the few bright spots in the stock market.

Could Gilead News Be Good For Biotech ETFs?

iShares U.S. Healthcare ETF

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

A dashboard with metrics of value, quality and momentum by industries.

Healthcare Dashboard For June

ALPS Medical Breakthroughs ETF

Biotechnology ETFs, including the ALPS Medical Breakthroughs ETF (SBIO), are on torrid paces in the second quarter. Yes, some of that bullishness is attributable to the industry’s efforts to vanquish the coronavirus, but there’s more to the story.

Biotech ETFs in the Spotlight, Why They’ll Remain There

IBB: A Technical Look At The Biotech Sector

Genmab - ADR

Innoviva

Trillium Therapeutics

Vanda Pharmaceuticals

XBiotech

These are the biotech stocks with the best value, fastest growth, and most momentum for Q3 2020.

Top Biotech Stocks for Q3 2020

Biotech funds are testing their 2015 highs, setting the stage for a major breakout or painful reversal.

Biotech Funds Testing Multi-Year Resistance

Deep Value ETF

In the race to develop a coronavirus vaccine, AstraZeneca (NYSE: AZN) and Gilead Sciences (NASDAQ: GILD) are two of the leading contenders and that could be the starting point of a massive marriage, according to recent reports.

3 Gilead-Heavy ETFs To Watch Amid The AstraZeneca-Gilead Rumor

Energy Select Sector SPDR Fund

Utilities Select Sector SPDR Fund

Investors could be well served by ETFs and stocks from sectors that house top-ranked industries.

Top ETFs & Stocks From Top-Ranked Sectors

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

How Are Biotech ETFs Reacting to Coronavirus Treatment News?

iShares Robotics & Artificial Intelligence Multisector ETF

US Global Jets ETF

Here we highlight some ETF areas that will make interesting investment options for investors amid the coronavirus crisis.

These ETF Areas Make Great Investment Choices in June

iShares North American Tech-Software ETF

iShares Morningstar Large-Cap Growth ETF

WisdomTree Cloud Computing Fund

Wall Street has staged a comeback since late March, leaving behind the rest of the world.

News for iShares Nasdaq Biotechnology ETF ETF (IBB)